Patents by Inventor Kennosuke KARUBE

Kennosuke KARUBE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250236642
    Abstract: As a technique that can be used for cancer immunotherapy of adult T-cell leukemia (ATL), provided is a pharmaceutical composition for treatment or prevention of adult T-cell leukemia, the pharmaceutical composition containing a peptide consisting of an amino acid sequence of any one of SEQ ID NOs: 1 to 68.
    Type: Application
    Filed: February 24, 2023
    Publication date: July 24, 2025
    Applicants: NEC Corporation, The University of Tokyo, University of the Ryukyus, KURUME UNIVERSITY
    Inventors: Kaoru UCHIMARU, Kazumi NAKANO, Yoshiko YOSHIHARA, Takuya FUKUSHIMA, Yuetsu TANAKA, Kennosuke KARUBE, Hiroaki MASUZAKI, Koichi OSHIMA, Hiroaki MIYOSHI
  • Publication number: 20220404363
    Abstract: As a technique enabling to simply and accurately diagnose human T cell leukemia virus type 1 (HTLV-1) related disease, there is provided a diagnostic method for an HTLV-1 related disease based on an amount of tumor necrosis factor receptor 2 (TNFR2) in a blood sample taken from a subject, wherein (1) it is determined based on an increase of the amount of TNFR2 that the subject suffers from, or is likely to develop, the HTLV-1 related disease; and/or (2) it is determined based on a decrease of the amount of TNFR2 that the subject is in remission, or is likely to be in remission, of the HTLV-1 related disease.
    Type: Application
    Filed: November 2, 2020
    Publication date: December 22, 2022
    Applicants: NEC CORPORATION, UNIVERSITY OF THE RYUKYUS
    Inventors: Yoshiko YOSHIHARA, Takuya FUKUSHIMA, Yuetsu TANAKA, Hiroaki MASUZAKI, Kennosuke KARUBE, Naoki IMAIZUMI